# Efficacy of Rotations Between Abiraterone Acetate and Apalutamide in mCRPC Patients

> **NCT03173859** · PHASE2 · WITHDRAWN · sponsor: **University of Athens**

## Conditions studied

- Prostatic Neoplasms, Castration-Resistant

## Interventions

- **DRUG:** Abiraterone
- **DRUG:** Apalutamide

## Key facts

- **NCT ID:** NCT03173859
- **Lead sponsor:** University of Athens
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2018-01
- **Primary completion:** 2020-12-31
- **Final completion:** 2020-12-31
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Delayed initiation
- **Last updated:** 2020-11-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03173859

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03173859, "Efficacy of Rotations Between Abiraterone Acetate and Apalutamide in mCRPC Patients". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03173859. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*